765 related articles for article (PubMed ID: 31520915)
1. Helenalin from Centipeda minima ameliorates acute hepatic injury by protecting mitochondria function, activating Nrf2 pathway and inhibiting NF-κB activation.
Li Y; Zeng Y; Huang Q; Wen S; Wei Y; Chen Y; Zhang X; Bai F; Lu Z; Wei J; Lin X
Biomed Pharmacother; 2019 Nov; 119():109435. PubMed ID: 31520915
[TBL] [Abstract][Full Text] [Related]
2. Protective Role of 4-Octyl Itaconate in Murine LPS/D-GalN-Induced Acute Liver Failure via Inhibiting Inflammation, Oxidative Stress, and Apoptosis.
Li R; Yang W; Yin Y; Zhang P; Wang Y; Tao K
Oxid Med Cell Longev; 2021; 2021():9932099. PubMed ID: 34457120
[TBL] [Abstract][Full Text] [Related]
3. Andrographolide ameliorates d-galactosamine/lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway.
Pan CW; Yang SX; Pan ZZ; Zheng B; Wang JZ; Lu GR; Xue ZX; Xu CL
Oncotarget; 2017 Jun; 8(25):41202-41210. PubMed ID: 28465482
[TBL] [Abstract][Full Text] [Related]
4. Oxyresveratrol prevents lipopolysaccharide/d-galactosamine-induced acute liver injury in mice.
Jia YN; Lu HP; Peng YL; Zhang BS; Gong XB; Su J; Zhou Y; Pan MH; Xu L
Int Immunopharmacol; 2018 Mar; 56():105-112. PubMed ID: 29414639
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of morin on lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting TLR4/NF-κB and activating Nrf2/HO-1 signaling pathways.
Tian Y; Li Z; Shen B; Zhang Q; Feng H
Int Immunopharmacol; 2017 Apr; 45():148-155. PubMed ID: 28213269
[TBL] [Abstract][Full Text] [Related]
6. Curcumin attenuates lipopolysaccharide/d-galactosamine-induced acute liver injury by activating Nrf2 nuclear translocation and inhibiting NF-kB activation.
Xie YL; Chu JG; Jian XM; Dong JZ; Wang LP; Li GX; Yang NB
Biomed Pharmacother; 2017 Jul; 91():70-77. PubMed ID: 28448872
[TBL] [Abstract][Full Text] [Related]
7. Nobiletin attenuates lipopolysaccharide/D‑galactosamine‑induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF‑κB‑mediated cytokine production.
He Z; Li X; Chen H; He K; Liu Y; Gong J; Gong J
Mol Med Rep; 2016 Dec; 14(6):5595-5600. PubMed ID: 27878238
[TBL] [Abstract][Full Text] [Related]
8. Maresin 1 protects against lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting macrophage pyroptosis and inflammatory response.
Yang W; Tao K; Zhang P; Chen X; Sun X; Li R
Biochem Pharmacol; 2022 Jan; 195():114863. PubMed ID: 34861244
[TBL] [Abstract][Full Text] [Related]
9. Propofol attenuates inflammatory response and apoptosis to protect d-galactosamine/lipopolysaccharide induced acute liver injury via regulating TLR4/NF-κB/NLRP3 pathway.
Zhang Z; Tian L; Jiang K
Int Immunopharmacol; 2019 Dec; 77():105974. PubMed ID: 31735662
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of tormentic acid from Potentilla chinensis against lipopolysaccharide/D-galactosamine induced fulminant hepatic failure in mice.
Lin X; Zhang S; Huang R; Tan S; Liang S; Wu X; Zhuo L; Huang Q
Int Immunopharmacol; 2014 Apr; 19(2):365-72. PubMed ID: 24560903
[TBL] [Abstract][Full Text] [Related]
11. Role of α-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis.
Xia X; Su C; Fu J; Zhang P; Jiang X; Xu D; Hu L; Song E; Song Y
Int Immunopharmacol; 2014 Oct; 22(2):293-302. PubMed ID: 25046589
[TBL] [Abstract][Full Text] [Related]
12. Protective Effects of Sesquiterpenoids from the Root of Panax ginseng on Fulminant Liver Injury Induced by Lipopolysaccharide/d-Galactosamine.
Wang W; Zhang Y; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
J Agric Food Chem; 2018 Jul; 66(29):7758-7763. PubMed ID: 29974747
[TBL] [Abstract][Full Text] [Related]
13. Hepatoprotective effect of chiisanoside from Acanthopanax sessiliflorus against LPS/D-GalN-induced acute liver injury by inhibiting NF-κB and activating Nrf2/HO-1 signaling pathways.
Bian X; Liu X; Liu J; Zhao Y; Li H; Zhang L; Li P; Gao Y
J Sci Food Agric; 2019 May; 99(7):3283-3290. PubMed ID: 30552777
[TBL] [Abstract][Full Text] [Related]
14. 4-hydroxybenzo[d]oxazol-2(3H)-one ameliorates LPS/D-GalN-induced acute liver injury by inhibiting TLR4/NF-κB and MAPK signaling pathways in mice.
Wang H; Wei X; Wei X; Sun X; Huang X; Liang Y; Xu W; Zhu X; Lin X; Lin J
Int Immunopharmacol; 2020 Jun; 83():106445. PubMed ID: 32272395
[TBL] [Abstract][Full Text] [Related]
15. Madecassoside prevents acute liver failure in LPS/D-GalN-induced mice by inhibiting p38/NF-κB and activating Nrf2/HO-1 signaling.
Wang W; Wu L; Li Q; Zhang Z; Xu L; Lin C; Gao L; Zhao K; Liang F; Zhang Q; Zhou M; Jiang W
Biomed Pharmacother; 2018 Jul; 103():1137-1145. PubMed ID: 29715757
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of genistein on lipopolysaccharide/D-galactosamine- induced hepatic failure in mice.
Lin X; Zhang S; Huang R; Wei L; Liang C; Chen Y; Lv S; Liang S; Wu X; Huang Q
Biol Pharm Bull; 2014; 37(4):625-32. PubMed ID: 24818258
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of tenuigenin on lipopolysaccharide and d-galactosamine-induced acute liver injury.
Jia R; Zhang H; Zhang W; Zhao H; Zha C; Liu Y
Microb Pathog; 2017 Nov; 112():83-88. PubMed ID: 28958948
[TBL] [Abstract][Full Text] [Related]
18. Isoliquiritigenin alleviates LPS/ D-GalN-induced acute liver failure by activating the PGC-1α/ Nrf2 pathway to reduce oxidative stress and inflammatory response.
Wang L; Wang X; Kong L; Wang S; Huang K; Wu J; Wang C; Sun H; Liu K; Meng Q
Int Immunopharmacol; 2021 Nov; 100():108159. PubMed ID: 34555641
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the crosstalk between Keap1/Nrf2/HO-1 and NF-κB signaling pathways by Tomatidine protects against inflammation/oxidative stress-driven fulminant hepatic failure in mice.
Abdulaal WH; Omar UM; Zeyadi M; El-Agamy DS; Alhakamy NA; Ibrahim SRM; Almalki NAR; Asfour HZ; Al-Rabia MW; Mohamed GA; Elshal M
Int Immunopharmacol; 2024 Mar; 130():111732. PubMed ID: 38402834
[TBL] [Abstract][Full Text] [Related]
20. Endotoxin tolerance ameliorates lipopolysaccharide/D-galactosamine-induced acute liver failure by negative regulation of the NF-κB/NLRP3 and activation of Nrf2/HO-1 via Sitr1.
Shi H; Xie X; Zheng S; Chen H; Liu C; Li S; Lu M
Int Immunopharmacol; 2024 May; 132():111994. PubMed ID: 38581992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
